« Previous
Next »
Psychoneuroendocrinology
Volume 31, Issue 6
, Pages 781-785
, July 2006
Corticosterone response to acute stress in a mouse model of Fragile X syndrome
References
- Beckel-Mitchener, A.C., Churchill, J.D., Kim, S., Estrada, C.M., Greenough, W.T., 2003. Prolonged elevation of serum glucocorticoid (corticosterone) levels in Fragile X knockout mice after acute restraint. Proceedings of the Society for Neuroscience, Program No. 646.645.
- . FMR1 and the fragile X syndrome: human genome epidemiology review. Genet. Med. 2001;3:359–371
- . Sex difference in resting pituitary–adrenal function in the rat. Am. J. Physiol. 1963;205:807–815
- . Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci. 1999;22:422–426
- . Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology. 2002;27:855–872
- . The role of the hippocampus in feedback regulation of the hypothalamic–pituitary–adrenocortical axis. Endocr. Rev. 1991;12:118–134
- . Deletion of FMR1 in Purkinje Cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome. Neuron. 2005;47:339–352
- . Stress induced changes in cortical and hypothalamic c-fos expression are altered in Fragile X mutant mice. Mol. Brain Res. 2004;131:101–109
- . Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology. 2005;30:225–242
- . RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron. 2003;37:417–431
- . Learning during stressful times. Learn Mem. 2004;11:137–144
- . FMRP expression as a potential prognostic indicator in fragile X syndrome. Am. J. Med. Genet. 1999;84:250–261
- . Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav. Pharmacol. 2004;15:433–442
- . Cortisol and social stressors in children with fragile X: a pilot study. J. Dev. Behav. Pediatr. 2000;21:278–282
- . Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J. Neurosci. 2005;25:7385–7392
PII: S0306-4530(06)00035-7
doi: 10.1016/j.psyneuen.2006.02.008
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
Psychoneuroendocrinology
Volume 31, Issue 6
, Pages 781-785
, July 2006
